CTRI/2025/11/096889尚未招募3 期
A RANDOMIZED CLINICO-COMPARATIVE TRAIL TO EVALUATE THE EFFICACY AND SAFETY OF GHANADI VATI AND KANCHNARA GUDIKA IN THE MANAGEMENT OF DHATVAGNIMANDYA W.S.R. TO HYPOTHYROIDISM
Dr Divya Singh Charan1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年11月15日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- The Primary outcomes are Any changes in the value of serum TSH.
研究概览
简要总结
It is a randomized, prospective, open-label, interventional comparative clinical trial.
The trial consists of three groups: one will receive Ghanadi Vati, the second
group will receive Kanchnara Gudika and the third group will receive
both Ghanadi Vati,and Kanchnara Gudika together
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients having sign and symptom of Dhatwagnimandya (Hypothyroidism) will be selected for the present study.
- •Patients having age between 18 to 60 years of either sex.Already diagnosed and Fresh patients of TSH level 5-12 mlU/L.
- •Patients, willing to give written informed consent to participate in the study.
排除标准
- •Participants will be excluded if they have TSH levels more than12 mlU/L.
- •congenital hypothyroidism and secondary hypothyroidism.
- •any type of thyroid surgery.Patients below 18 years and above 60 years of age.
- •uncontrolled Diabetes mellitus.
- •poorly controlled hypertension.
- •clinical evidence of Heart failure.Other exclusion includesAlcoholics and/or drug abusers.
- •Pregnant/lactating woman.
- •Any other condition which the Investigator thinks may jeopardize the study.
结局指标
主要结局
The Primary outcomes are Any changes in the value of serum TSH.
时间窗: Total study time 90days follow up at every 1 month
次要结局
- Change in T3 & T4.(Changes in status of Agni (Jatharagni Assessment).Change in RAND 36- Item Health Survey 1.0 Questionnaire.)
研究者
Dr Divya singh charan
Maharao Skekhaji Regional Ayurveda Research Institute Bani Park,Jhotwara road, Jaipur
研究点 (1)
Loading locations...
相似试验
尚未招募
Unknown
Comparing the Efficacy and Safety Sleep Gummy versus Melatonin Monotherapy in Adults with Sleep Disorders- Randomized controlled studyCTRI/2025/07/090648Ahana Hospitals LLP150
尚未招募
4 期
Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic CancerNCT07302841Tianjin Medical University Cancer Institute and Hospital28
招募中
不适用
A clinical study to evaluate the safety and effectiveness of Amrutveni DandroQit Oil in reducing dandruff and improving scalp condition in adults with mild to moderate dandruffCTRI/2025/10/096434Sahyadri Bio Labs Pvt. Ltd.36
招募中
不适用
Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver CancerNCT07356531JIANGSU SHENMING Medical Technology CO., Ltd216
尚未招募
2 期
A Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy ProgressionNCT07289048Union Hospital, Tongji Medical College, Huazhong University of Science and Technology35